Search Results

Alzheimer's disease: Seeing the signs early

Author: Leifer, Bennett P.

Source: Journal of the American Academy of Nurse Practitioners, Volume 21, Number 11, November 2009 , pp. 588-595(8)

Publisher: Blackwell Publishing

Modeling the Cost-Effectiveness of Galantamine for Mild to Moderately Severe Alzheimer's Disease in Korea

Author: Suh, Guk-Hee

Source: Value in Health, Volume 12, Supplement 3, November/December 2009 , pp. S49-S54(1)

Publisher: Blackwell Publishing

Mediators of tau phosphorylation in the pathogenesis of Alzheimer's disease

Authors: Hanger, Diane P; Seereeram, Anjan; Noble, Wendy

Source: Expert Review of Neurotherapeutics, Volume 9, Number 11, November 2009 , pp. 1647-1666(20)

Publisher: Expert Reviews

First analysis of pharma uptake after NICE approval

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 587, 2009-09-19 , pp. 5-5(1)

Publisher: Adis International

Case Report: Combined Use of Donepezil and Galantamine in Mixed Dementia

Authors: Obering, Crystal; Batrash, Ahmad

Source: Journal of the American Geriatrics Society, Volume 57, Number 10, October 2009 , pp. 1934-1935(2)

Publisher: Blackwell Publishing

Treatment of Mild Cognitive Impairment (MCI)

Author: Farlow, M. R.

Source: Current Alzheimer Research, Volume 6, Number 4, August 2009 , pp. 362-367(6)

Publisher: Bentham Science Publishers

Galantamine: Myocardial infarction and fatal heart arrest in elderly patients: 2 case reports

Source: Reactions, Volume 1, Number 1264, 2009-08-08 , pp. 19-19(1)

Publisher: Adis International

Galantamine improves apomorphine-induced deficits in prepulse inhibition via muscarinic ACh receptors in mice

Authors: Yano, K; Koda, K; Ago, Y; Kobayashi, H; Kawasaki, T; Takuma, K; Matsuda, T

Source: British Journal of Pharmacology, Volume 156, Number 1, January 2009 , pp. 173-180(8)

Publisher: Blackwell Publishing

Galantamine: Bullous pemphigoid in an elderly patient: case report

Source: Reactions, Volume 1, Number 1257, 2009-06-20 , pp. 21-22(2)

Publisher: Adis International

Persistence with Cholinesterase Inhibitor Therapy for Dementia: An Observational Administrative Health Database Study

Authors: Herrmann, Nathan; Binder, Carin; Dalziel, William; Smyth, Steve; Camacho, Fernando

Source: Drugs & Aging, Volume 26, Number 5, May 5 2009 , pp. 403-407(5)

Publisher: Adis International

Optimal Dosing of Galantamine in Patients with Mild or Moderate Alzheimer's Disease: Post Hoc Analysis of a Randomized, Double-Blind, Placebo-Controlled Trial

Authors: Aronson, Stephen; >Bart Van Baelen,; Kavanagh, Shane; Schwalen, Susanne

Source: Drugs & Aging, Volume 26, Number 3, 2009 , pp. 231-239(9)

Publisher: Adis International

Galantamine: Bradycardia in an elderly patient: case report

Source: Reactions, Volume 1, Numbers 1247-1248, 2009-04-11 , pp. 19-19(1)

Publisher: Adis International

Novel Regimens and Delivery Systems in the Pharmacological Treatment of Alzheimer's Disease

Authors: Bassil, Nazem; Grossberg, George T.

Source: CNS Drugs, Volume 23, Number 4, 2009 , pp. 293-307(15)

Publisher: Adis International

Galantamine: Nightmares in an elderly patient: case report

Source: Reactions, Volume 1, Number 1249, 2009-04-25 , pp. 22-22(1)

Publisher: Adis International

Carotid Intima-Media Thickness as a Predictor of Response to Cholinesterase Inhibitors in Alzheimer's Disease: An Open-Label Trial

Authors: Modrego, Pedro J.; Rios, Consuelo; Trullen, José M. Pérez; García-Gómara, Maria J.; Errea, José M.

Source: CNS Drugs, Volume 23, Number 3, 2009 , pp. 253-260(8)

Publisher: Adis International

Recent advances in treating cognitive impairment in schizophrenia

Author: Galletly, Cherrie

Source: Psychopharmacology, Volume 202, Numbers 1-3, January 2009 , pp. 259-273(15)

Publisher: Springer

Galantamine-induced improvements in cognitive function are not related to alterations in α₄β₂ nicotinic receptors in early Alzheimer's disease as measured in vivo by 2-[¹⁸F]Fluoro-A-85380 PET

Authors: Ellis, J.; Nathan, P.; Villemagne, V.; Mulligan, R.; Saunder, T.; Young, K.; Smith, C.; Welch, J.; Woodward, M.; Wesnes, K.; Savage, G.; Rowe, C.

Source: Psychopharmacology, Volume 202, Numbers 1-3, January 2009 , pp. 79-91(13)

Publisher: Springer

Cholinesterase Inhibitors and Beyond

Authors: Pepeu, Giancarlo; Giovannini, Maria G.

Source: Current Alzheimer Research, Volume 6, Number 2, April 2009 , pp. 86-96(11)

Publisher: Bentham Science Publishers

Cholinergic modulation of the cerebral metabolic response to citalopram in Alzheimer's disease

Authors: Smith, Gwenn S.; Kramer, Elisse; Ma, Yilong; Hermann, Carol R.; Dhawan, Vijay; Chaly, Thomas; Eidelberg, David

Source: Brain, Volume 132, Number 2, 5 February 2009 , pp. 392-401(10)

Publisher: Oxford University Press

AN UNUSUAL CASE OF NIGHTMARES WITH GALANTAMINE

Authors: Iraqi, Abid; Hughes, Terry Lynn

Source: Journal of the American Geriatrics Society, Volume 57, Number 3, March 2009 , pp. 565-565(1)

Publisher: Blackwell Publishing